enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Peter S. Kim - Wikipedia

   en.wikipedia.org/wiki/Peter_S._Kim

   Peter S. Kim (born April 27, 1958) is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.

3. Exploratory Science Center - Wikipedia

   en.wikipedia.org/wiki/Exploratory_Science_Center

   The Exploratory Science Center site was originally occupied by a Schering-Plough innovation research site, which opened in 2006 and focused on small molecule drugs. [11] [12] The innovation research site became part of Merck & Co. when it merged with Schering-Plough in 2009. [13]

4. Merck Group - Wikipedia

   en.wikipedia.org/wiki/Merck_Group

   The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...

5. Merck & Co. - Wikipedia

   en.wikipedia.org/wiki/Merck_&_Co.

   Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]

6. Clinical pharmaceutical scientist - Wikipedia

   en.wikipedia.org/wiki/Clinical_pharmaceutical...

   The term clinical pharmaceutical scientist is distinct from the term pharmaceutical scientist, in that a clinical pharmaceutical scientist is a practicing clinical pharmacist involved in science relating to the discovery and/or development of pharmaceuticals, the development of new knowledge improving the use of pharmaceuticals in clinical practice, or any other subfield of pharmaceutical ...

7. Merck stops testing combo drug for skin cancer as more ... - AOL

   www.aol.com/news/merck-stops-testing-combo-drug...

   This is the latest setback for the experimental drug, vibostolimab, and the related promising new class of immunotherapies called anti-TIGIT. Merck was testing vibostolimab along with Keytruda ...